Similar medications and substitutes for TRALOKINUMAB-LDRM
In short: Adbry (TRALOKINUMAB-LDRM) belongs to the Interleukin-13 Antagonist class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Adbry is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Adbry in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.